Streetbeat News

Stock Prices

BMRN

Analyst ratings for Biomarin Pharmaceutical (NASDAQ:BMRN) show a mix of opinions, with a recent shift towards more bullish views. The average 12-month price target has increased to $100.73. Key financial indicators suggest challenges in profitability and efficiency, despite notable revenue growth.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 12:00 pm

FTRE

Fortrea Holdings (NASDAQ:FTRE) has been analyzed by four analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $37.00, with a high of $43.00 and a low of $33.00. Analyst actions include both upgrades and downgrades, reflecting diverse perspectives on the company's performance and market position. Fortrea, a contract research organization, has shown positive revenue growth and a strong net margin but faces challenges in ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 12:00 pm

LEGN

Legend Biotech (NASDAQ:LEGN) has received mixed analyst ratings over the past three months, with a total of 14 analysts offering their perspectives. The ratings include 8 bullish, 6 somewhat bullish, and no bearish views. The 12-month price targets suggest an average of $84.07, with a high of $87.00 and a low of $65.00, marking a 10.62% increase from the previous average of $76.00. The company's financial health shows significant revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 12:00 pm

WULF

TeraWulf's stock price declined following the announcement of disappointing Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 11:59 am

MPW

RBC Capital analyst Michael Carroll downgraded Medical Properties Trust (MPW) from Outperform to Sector Perform and set a new price target of $5. This adjustment reflects a more cautious outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 11:59 am

LUNR

Intuitive Machines shares dropped following the announcement of Q1 financial results and FY24 revenue guidance that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 11:58 am

CHRD

Piper Sandler analyst Mark Lear maintains an Overweight rating on Chord Energy (NASDAQ:CHRD) and raises the price target from $230 to $231.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 11:49 am

TMC

TMC Metals shares declined following the announcement of disappointing Q1 GAAP EPS results, indicating the company's financial performance fell short of market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 11:46 am

HOOD

Robinhood Markets' shares are experiencing an uptick, potentially due to Roaring Kitty's return, which could lead to increased platform usage by retail investors.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 11:41 am

HD

Home Depot Inc (NYSE:HD) reported a Q1 FY24 sales decline of 2.3% Y/Y to $36.418 billion, missing analyst estimates. Customer transactions and comparable sales also fell. Despite a decrease in gross profit and operating income, EPS of $3.63 beat estimates. The company reiterated its FY24 EPS and sales outlook, slightly below consensus estimates. Shares rose 0.60% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

May 14, 2024 | 11:39 am